1475 related articles for article (PubMed ID: 18707706)
21. Use of extended pattern technique for initial prostate biopsy.
Siu W; Dunn RL; Shah RB; Wei JT
J Urol; 2005 Aug; 174(2):505-9. PubMed ID: 16006881
[TBL] [Abstract][Full Text] [Related]
22. The 20-core prostate biopsy protocol--a new gold standard?
Ravery V; Dominique S; Panhard X; Toublanc M; Boccon-Gibod L; Boccon-Gibod L
J Urol; 2008 Feb; 179(2):504-7. PubMed ID: 18076947
[TBL] [Abstract][Full Text] [Related]
23. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
[TBL] [Abstract][Full Text] [Related]
24. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
[TBL] [Abstract][Full Text] [Related]
25. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer.
Fowler JE; Bigler SA; Miles D; Yalkut DA
J Urol; 2000 Mar; 163(3):813-8. PubMed ID: 10687983
[TBL] [Abstract][Full Text] [Related]
26. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features.
Boccon-Gibod LM; Dumonceau O; Toublanc M; Ravery V; Boccon-Gibod LA
Eur Urol; 2005 Dec; 48(6):895-9. PubMed ID: 16125298
[TBL] [Abstract][Full Text] [Related]
27. Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer.
Thomas C; Wiesner C; Melchior S; Gillitzer R; Schmidt F; Thüroff JW
J Urol; 2008 Nov; 180(5):1938-41; discussion 1941. PubMed ID: 18801501
[TBL] [Abstract][Full Text] [Related]
28. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
Lane BR; Zippe CD; Abouassaly R; Schoenfield L; Magi-Galluzzi C; Jones JS
J Urol; 2008 May; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
[TBL] [Abstract][Full Text] [Related]
29. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
Auprich M; Augustin H; Budäus L; Kluth L; Mannweiler S; Shariat SF; Fisch M; Graefen M; Pummer K; Chun FK
BJU Int; 2012 Jun; 109(11):1627-35. PubMed ID: 21939492
[TBL] [Abstract][Full Text] [Related]
30. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?
Djavan B; Ravery V; Zlotta A; Dobronski P; Dobrovits M; Fakhari M; Seitz C; Susani M; Borkowski A; Boccon-Gibod L; Schulman CC; Marberger M
J Urol; 2001 Nov; 166(5):1679-83. PubMed ID: 11586201
[TBL] [Abstract][Full Text] [Related]
31. Predictors of prostate cancer on extended biopsy in patients with high-grade prostatic intraepithelial neoplasia: a multivariate analysis model.
Abdel-Khalek M; El-Baz M; Ibrahiem el-H
BJU Int; 2004 Sep; 94(4):528-33. PubMed ID: 15329106
[TBL] [Abstract][Full Text] [Related]
32. The value of free and total prostate specific antigen in identifying patients for prostatic biopsy and its relationship to Gleason score and number of positive cores.
Bulbul MA; Khauli RB; Nasr R; Hemady K; Wazzan W
J Med Liban; 2000; 48(2):59-62. PubMed ID: 11028151
[TBL] [Abstract][Full Text] [Related]
33. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.
Akhavan A; Keith JD; Bastacky SI; Cai C; Wang Y; Nelson JB
BJU Int; 2007 Apr; 99(4):765-9. PubMed ID: 17378840
[TBL] [Abstract][Full Text] [Related]
34. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
Barocas DA; Cowan JE; Smith JA; Carroll PR;
J Urol; 2008 Oct; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731
[TBL] [Abstract][Full Text] [Related]
35. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection.
Gao X; Mohideen N; Flanigan RC; Waters WB; Wojcik EM; Leman CR
J Urol; 2000 Dec; 164(6):1982-6. PubMed ID: 11061896
[TBL] [Abstract][Full Text] [Related]
36. The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy.
De Nunzio C; Trucchi A; Miano R; Stoppacciaro A; Fattahi H; Cicione A; Tubaro A
J Urol; 2009 Mar; 181(3):1069-74; discussion 1074-5. PubMed ID: 19150546
[TBL] [Abstract][Full Text] [Related]
37. Predicting the risk of patients with biopsy Gleason score 6 to harbor a higher grade cancer.
Gofrit ON; Zorn KC; Taxy JB; Lin S; Zagaja GP; Steinberg GD; Shalhav AL
J Urol; 2007 Nov; 178(5):1925-8. PubMed ID: 17868725
[TBL] [Abstract][Full Text] [Related]
38. Combined prostate-specific antigen density and biopsy features to predict "clinically insignificant" prostate cancer.
Loeb S; Roehl KA; Thaxton CS; Catalona WJ
Urology; 2008 Jul; 72(1):143-7. PubMed ID: 18436287
[TBL] [Abstract][Full Text] [Related]
39. A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.
Potters L; Purrazzella R; Brustein S; Fearn P; Leibel SA; Kattan MW
Cancer; 2002 Oct; 95(7):1451-6. PubMed ID: 12237913
[TBL] [Abstract][Full Text] [Related]
40. Does repeat biopsy affect the prognosis of patients with prostate cancer treated with radical prostatectomy? Analysis by the number of cores taken at initial biopsy.
Park M; You D; Yoon JH; Jeong IG; Song C; Hong JH; Ahn H; Kim CS
BJU Int; 2012 May; 109(10):1474-9. PubMed ID: 21933324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
